Sanket Koul

Indian pharma may face muted US growth in FY27 on gRevlimid pressure

Ind-Ra says Indian drugmakers will still see 10% revenue growth in FY27 driven by domestic demand and CDMO traction, despite weaker US sales after Revlimid expiry

Luxury shift drives 17% rise in average apartment sizes across top cities

Premiumisation of housing fuels demand for larger units, with NCR, Chennai and Bengaluru posting the sharpest gains in average apartment sizes over two years

France set to simplify visa norms for Indian students, says Macron

Macron announced plans to triple the number of Indian students in France and launched an Indo-French AI health centre, as both nations deepen cooperation in AI, mobility and nuclear R&D

Central Park unveils ₹1,200-cr luxury project Belanova along Sohna Road

Central Park will invest ₹1,200 crore in its new ultra-luxury Belanova project in Gurugram, targeting sales of up to ₹3,000 crore with phased pricing and strong early demand

Chemists warn PM that fake AI prescriptions are enabling illegal drug sales

AIOCD has urged the Prime Minister to ban AI-generated prescriptions, alleging they are being misused by unregulated e-pharmacies to sell restricted medicines, posing a serious public health risk

Indian Reits distributed over ₹2,450 cr to 380K unit holders in Q3FY26

India's five listed REITs distributed over Rs 2,450 crore to 380,000 unitholders in Q3 FY26, backed by strong leasing momentum, improving occupancies and regulatory moves expanding access to capital

Govt seeks views on exempting 350 medical devices from GTE norms

The pharmaceuticals department has invited stakeholder comments on proposed changes to the list of 350-plus medical devices exempt from GTE rules, with submissions open until February

Lead-to-buy cycle for homes above ₹3 cr jumps 58% amid selective demand

Homes priced above ₹3 crore saw a 58% rise in lead-to-buy conversion time in 2025 as buyers became more selective, even as overall housing conversion time fell 18% due to faster big-ticket purchases

Prices for South Delhi luxury floors up 34% in 2025 on HNI backing

The steady migration of affluent households from other parts of Delhi towards South Delhi, driven by its superior social infrastructure, iconic value and lifestyle offering, has boosted demand

Biocon Q3FY26 results: Revenue up 9%, net profit rises on generics push

Board gives in-principle nod to make Biocon Biologics a wholly owned subsidiary as Q3 net profit climbs to Rs 143.8 crore

IIT Bombay, Columbia Univ to set up AI centre for manufacturing innovation

Joint centre, initiated by Union Education Ministry, will build scalable, human-centric AI systems for manufacturing sectors including semiconductors and robotics

Centre to formally launch IIT-Madras's Bharat Bodhan AI on Thursday

Education Minister Dharmendra Pradhan chairs AI roundtable with edtech founders ahead of launch of IIT Madras-anchored Bharat Bodhan AI Foundation

Draft rules scrap provisional ethics committee registration stage

Health Ministry proposes removing provisional registration for ethics committees, shifting to single-stage approval to streamline clinical research and cut regulatory delays

US-Bangladesh pact unlikely to impact India's pharma, medtech exports

Industry executives say the US-Bangladesh reciprocal trade agreement is unlikely to materially affect India's pharma and medtech exports, given India's scale and established FDA-approved supply chains

CBSE announces digital evaluation of Class 12 board papers from Feb 17

CBSE has announced the introduction of on-screen marking for Class 12 board exams from February 17, aiming to improve efficiency, transparency and reduce time and logistical costs

Fortis, IHH launch innovation platform for medtech, healthtech startups

IHH Healthcare and Fortis Healthcare have launched IHH Catalyst, a national platform to help execution-ready medtech and healthtech startups move from pilots to hospital adoption and scale

Noida sheds insolvency-hit budget market tag as luxury housing rises

Revised FAR/FSI limits, height relaxations lead to increased investor interest

Medtech manufacturing industry divided on policy for refurbished devices

Domestic device makers warn of safety and dumping risks, while MNC bodies back affordability benefits as the Centre reviews policy on refurbished high-end medical device imports

Budget announcements to position India as value-led biopharma ecosystem

Pharma-focused Budget 2026 measures could help India move beyond generics by boosting biologics, biosimilars, regulatory capacity and early-stage innovation, analysts say

Only 34% of day care cancer centres approved for FY26 are functional

Just 102 of the 297 day care cancer centres approved for FY26 are operational so far, with states such as Telangana, Bihar and Karnataka reporting a higher share of functional facilities